Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1485-1490

  Sei, Shizuko ^a   Akiyoshi, Hiroya ^b   Bernard, Jordana ^d   Venzon, David J ^d   Fox, Cecil H ^d   Schwartzentruber, Douglas J ^d   Anderson, Barry D ^c   Kopp, Jeffrey B ^d   Mueller, Brigitta U ^d   Pizzo, Philip A ^d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c GEORGETOWN UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; CHILD; CLINICAL ARTICLE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN SITU HYBRIDIZATION; INFANT; LYMPHOID TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 19244363468     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1485     Document Type: Article

References (15)

1. Aoki-Sei S, Yarchoan R, Kageyama S, et al. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res Hum Retroviruses 1992;8:1263-70.
2. Markowitz M, Saag M, Powderly WG, et al. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med 1995;333:1534-9.
3. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
4. Centers for Disease Control. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994;43:1-9.
5. Sei S, Kleiner DE, Kopp JB, et al. Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunode-ficiency virus type 1 infection assessed by polymerase chain reaction. J Infect Dis 1994;170:325-33.
6. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Cause WC, Sher A. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol 1993;151:1430-40.
7. Goodman RE, Nestle F, Naidu YM, et al. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-γ. J Immunol 1994;152:5189-98.
8. Biberfeld P, Portwit-Ksiazek A, Bottiger B, Morfeldt-Mansson L, Biberfeld G. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res 1985; 45(suppl):4665-70.
9. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
10. Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-65.
11. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-replicating lymph nodes. J Clin Invest 1990;86:148-59.
12. + T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-9.
13. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
14. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-27.
15. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-73.